Steris (STE) EBITDA Margin Growth (5y) (2023 - 2026)
Powered by 
Analysis
Steris (STE) EBITDA Margin Growth (5y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 178.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.42 Bn | 119.20 Bn | 1.96 Bn |
| 3 | Medtronic | 118.24 Bn | 109.42 Bn | 6.34 Bn |
| 4 | Stryker | 105.02 Bn | 101.55 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.48 Bn | 65.94 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn |
| 8 | Dexcom | 32.34 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.16 Bn | 17.75 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,767.00 |
| Mar 31, 2026 | 343.00 |
| Dec 31, 2025 | 8.00 |
| Sep 30, 2025 | -48.00 |
| Jun 30, 2025 | 37.00 |
| Mar 31, 2025 | -457.00 |
| Dec 31, 2024 | -49.00 |
| Sep 30, 2024 | -67.00 |
| Jun 30, 2024 | -130.00 |
| Mar 31, 2024 | -276.00 |
| Dec 31, 2023 | 746.00 |
| Sep 30, 2023 | -23.00 |
| Jun 30, 2023 | 193.00 |